+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of tissue transglutaminase in age-associated ventricular stiffness



Role of tissue transglutaminase in age-associated ventricular stiffness



Amino Acids 49(3): 695-704



Aging is associated with increased cardiomyocyte loss, left-ventricular hypertrophy, and the accumulation of extracellular matrix, which results in declining cardiac function. The role of the matrix crosslinking enzyme, tissue transglutaminase (TG2), in age-related myocardial stiffness, and contractile function remains incompletely understood. In this study, we examined the role of TG2 in cardiac function, and determined whether TG2 inhibition can prevent age-associated changes in cardiac function. Male Fisher rats (18-month-old) were administered the transglutaminase inhibitor cystamine (study group) or saline (age-matched controls) for 12 weeks via osmotic mini-pumps. Cardiac function was determined by echocardiography and invasive pressure-volume loops. Rat hearts were dissected out, and TG2 expression, activity, and S-nitrosation were determined. Young (6-month-old) males were used as controls. TG2 activity significantly increased in the saline-treated but not in the cystamine-treated aging rat hearts. TG2 expression also increased with age and was unaltered by cystamine treatment. Aged rats showed increased left ventricular (LV) end-systolic dimension and a decrease in fractional shortening compared with young, which was not affected by cystamine. However, cystamine treatment preserved the preload-independent index of LV filling pressure and restored end-diastolic pressure, end-diastolic pressure-volume relationships, and arterial elastance toward young. An increase in TG2 activity contributes to age-associated increase in diastolic stiffness, thereby contributing to age-associated diastolic dysfunction. TG2 may thus represent a novel target for age-associated diastolic heart failure.

(PDF emailed within 0-6 h: $19.90)

Accession: 058791597

Download citation: RISBibTeXText

PMID: 27438265

DOI: 10.1007/s00726-016-2295-z


Related references

Thrombin upregulates tissue transglutaminase in endothelial cells: a potential role for tissue transglutaminase in stability of atherosclerotic plaque. Arteriosclerosis, Thrombosis, and Vascular Biology 21(10): 1689-1694, 2001

Exercise, vascular stiffness, and tissue transglutaminase. Journal of the American Heart Association 3(2): E000599, 2014

Polyglutamine domains are substrates of tissue transglutaminase: Does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases?. Journal of Neurochemistry 69(1): 431-434, 1997

Tissue transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype--implications for the role of transglutaminase in coeliac disease. Bmc Immunology 13: 20, 2012

The role of tissue transglutaminase (transglutaminase type II) for the intestinal manifestations of murine semi-allogenic graft-versus-host disease. Journal of Autoimmunity 18(1): 1-8, 2002

Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circulation Research 107(1): 117-125, 2010

Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases?. Neurochemistry International 40(1): 53-67, 2001

Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice. American Journal of Physiology. Heart and Circulatory Physiology 305(6): H803-H810, 2013

Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca2+ homeostasis. Amino Acids 44(1): 251-260, 2013

Tissue Transglutaminase Modulates Vascular Stiffness and Function Through Crosslinking-Dependent and Crosslinking-Independent Functions. Journal of the American Heart Association 6(2), 2018

Human tissue transglutaminase enzyme linked immunosorbent assay outperforms both the guinea pig based tissue transglutaminase assay and anti-endomysium antibodies when screening for coeliac disease. European Journal of Pediatrics 161(5): 284-287, 2002

Role of Substrate Stiffness in Tissue Spreading: Wetting Transition and Tissue Durotaxis. Langmuir 2018, 2018

Role of tissue transglutaminase in celiac disease. Journal of Pediatric Gastroenterology and Nutrition 30(3): 232-240, 2000

Tissue transglutaminase: a possible role in neurodegenerative diseases. Progress in Neurobiology 61(5): 439-463, 2000

The role of tissue transglutaminase in hepatocyte apoptosis. Hepatology 36(4 Part 2): 379A, 2002